Secor Alicia
SEC insider (Form 3/4/5 filer). CIK 0001584516. Director at ZEVRA THERAPEUTICS, INC. (ZVRA) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in BOSTON, MA.
Companies Secor Alicia has filed insider reports for
- ZEVRA THERAPEUTICS, INC. (ZVRA): Director
- G1 Therapeutics, Inc. (GTHX): Director
Secor Alicia
CIK: 0001584516
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 4, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
30K shares- - Dec 2, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
45K shares- - Sep 18, 2024GTHX
G1 Therapeutics, Inc.
DispositionDirect20K shares- - Sep 18, 2024GTHX
G1 Therapeutics, Inc.
Tender OfferDirect10K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 |  ZVRA ZEVRA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Dec 2, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 45,000 | - | - | Direct |
| Sep 18, 2024 |  GTHX G1 Therapeutics, Inc. | Disposition | 20,000 | - | $0 | Direct |
| Sep 18, 2024 | GTHX G1 Therapeutics, Inc. | Tender Offer | 10,000 | - | $0 | Direct |
1-4 of 4 transactions